AMENDED AND RESTATED CREDIT AGREEMENT AND GUARANTY dated as of March 9, 2020 by and among FOAMIX PHARMACEUTICALS INC., as the Borrower, MENLO THERAPEUTICS INC., as the Parent Guarantor, FOAMIX PHARMACEUTICALS LTD., as the Israeli Guarantor, THE...Credit Agreement and Guaranty • May 11th, 2020 • Menlo Therapeutics Inc. • Pharmaceutical preparations • New York
AMENDED AND RESTATED Credit Agreement and Guaranty, dated as of March 9, 2020 (this “Agreement”), by and among Foamix Pharmaceuticals Inc., a Delaware corporation (the “Borrower”), Foamix Pharmaceuticals Ltd., an Israeli limited liability company (the “Israeli Guarantor”), Menlo Therapeutics Inc., a Delaware corporation (the “Parent Guarantor”), certain Subsidiaries of the Parent Guarantor from time to time party hereto, Perceptive Credit Holdings II, LP, OrbiMed Royalty & Credit Opportunities III, LP, and each other lender that may from time to time become a party hereto (each a “Lender” and collectively, the “Lenders”), and Perceptive Credit Holdings II, LP, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).
David DomzalskiMenlo Therapeutics Inc. • May 11th, 2020 • Pharmaceutical preparations • New Jersey
This letter agreement (the “Agreement”) contains the terms and conditions of your employment with Foamix Pharmaceuticals Inc. (the “Company”), a subsidiary of Menlo Therapeutics Inc. (“Menlo”), effective as of March 9, 2020 the (the “Effective Date”). Unless stated otherwise below, this Agreement will supersede your previous employment agreement with the Company, dated November 27, 2017 (the “Previous Employment Agreement”). You may be interchangeably referred to as “you” or “the Executive” within this Agreement. Additionally, where the context permits, references to “the Company” shall include the Company, its subsidiaries and affiliates and any successor thereto. The terms and conditions of this Agreement are as follows:
Termination of Employment Agreement and ReleaseTermination of Employment Agreement • May 11th, 2020 • Menlo Therapeutics Inc. • Pharmaceutical preparations
This Termination of Employment and Release Agreement (this "Agreement") is entered by and between Foamix Pharmaceuticals Ltd. (the "Company") on the first part and Ilan Hadar I.D. No. 024298218 (the "Employee") on the second part;
AMENDED AND RESTATED SECURITY AGREEMENTAmended and Restated Security Agreement • May 11th, 2020 • Menlo Therapeutics Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED SECURITY AGREEMENT (as amended, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”), dated as of March _9, 2020, is made by and among Foamix Pharmaceuticals Inc., a Delaware corporation (the “Borrower”), Menlo Therapeutics Inc., a Delaware corporation (the “Parent Guarantor”), Foamix Pharmaceuticals Ltd., an Israeli limited liability company (the “Israeli Guarantor”), certain Subsidiaries of the Parent Guarantor party hereto or having acceded hereto pursuant to Section 22 (each a “Subsidiary Guarantor” and, together with the Parent Guarantor and the Israeli Guarantor, the “Guarantors”, and together with the Borrower, each a “Grantor” and, collectively, the “Grantors”), and PERCEPTIVE CREDIT HOLDINGS II, LP, as administrative agent for the Lenders referred to below (in such capacity, the “Administrative Agent”).
